Literature DB >> 1482282

Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine.

M J Kruesi1, S Fine, L Valladares, R A Phillips, J L Rapoport.   

Abstract

A relationship has been suggested between clinical presentation of paraphilias and obsessive-compulsive disorder (OCD) with respect to the unwanted repetitive nature and insight into the irrationality of the paraphiliac behavior. This has led to speculation that paraphiliac disorders might belong to an "obsessive compulsive spectrum." To address this issue, and because of the striking selective benefit of serotonin reuptake blocking antidepressants (such as clomipramine) in the treatment of OCD, 15 paraphiliacs entered a double-blind crossover comparison of clomipramine vs. desipramine preceded by a 2-week single-blind placebo period. Four subjects responded to placebo and were dropped from the study. Three others failed to complete the study. Although the study is limited by the small number of patients and the heterogeneity of the paraphilias, the observed benefit from both tricyclics (over the initial placebo) encourages further study. For the 8 subjects completing the protocol, there was no preferential response to the more specific serotonin reuptake inhibitor suggesting a difference in underlying pathophysiology between paraphilia and OCD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482282     DOI: 10.1007/bf01542257

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  16 in total

1.  Absence of placebo response in obsessive-compulsive disorder.

Authors:  M R Mavissakalian; B Jones; S Olson
Journal:  J Nerv Ment Dis       Date:  1990-04       Impact factor: 2.254

2.  Obsessive-compulsive and related disorders: a hidden epidemic.

Authors:  M A Jenike
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

3.  The placebo effect in agoraphobia--II.

Authors:  M Mavissakalian
Journal:  J Nerv Ment Dis       Date:  1988-07       Impact factor: 2.254

4.  Multiple paraphilic diagnoses among sex offenders.

Authors:  G G Abel; J V Becker; J Cunningham-Rathner; M Mittelman; J L Rouleau
Journal:  Bull Am Acad Psychiatry Law       Date:  1988

5.  The placebo effect in agoraphobia.

Authors:  M Mavissakalian
Journal:  J Nerv Ment Dis       Date:  1987-02       Impact factor: 2.254

6.  Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.

Authors:  W O Monteiro; H F Noshirvani; I M Marks; P T Lelliott
Journal:  Br J Psychiatry       Date:  1987-07       Impact factor: 9.319

7.  Differential response of seven subjects with autistic disorder to clomipramine and desipramine.

Authors:  C T Gordon; J L Rapoport; S D Hamburger; R C State; G B Mannheim
Journal:  Am J Psychiatry       Date:  1992-03       Impact factor: 18.112

Review 8.  Pharmacotherapy of childhood obsessive-compulsive disorder.

Authors:  H L Leonard; J L Rapoport
Journal:  Psychiatr Clin North Am       Date:  1989-12

9.  Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

Authors:  H L Leonard; S E Swedo; J L Rapoport; E V Koby; M C Lenane; D L Cheslow; S D Hamburger
Journal:  Arch Gen Psychiatry       Date:  1989-12

10.  Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men.

Authors:  M P Kafka
Journal:  J Clin Psychiatry       Date:  1991-02       Impact factor: 4.384

View more
  7 in total

1.  Compulsive Conditioned Sexual Responding of Male Japanese Quail in Extinction.

Authors:  Falih Köksal; Gülsen Kumru; Can Anarat; Michael Domjan; Nur Yeniçeri
Journal:  Arch Sex Behav       Date:  2021-01-04

Review 2.  Pharmacological interventions for those who have sexually offended or are at risk of offending.

Authors:  Omer Khan; Michael Ferriter; Nick Huband; Melanie J Powney; Jane A Dennis; Conor Duggan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

Review 3.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

4.  Obsessive-compulsive spectrum disorders.

Authors:  Andrea Allen; Audrey King; Eric Hollander
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

Review 5.  Epidemiologic and clinical updates on impulse control disorders: a critical review.

Authors:  Bernardo Dell'Osso; A Carlo Altamura; Andrea Allen; Donatella Marazziti; Eric Hollander
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09-07       Impact factor: 5.270

6.  Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

Authors:  Donatella Marazziti; Bernardo Dell'Osso
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-05-22

Review 7.  Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review.

Authors:  Valdemar Landgren; Josephine Savard; Cecilia Dhejne; Jussi Jokinen; Stefan Arver; Michael C Seto; Christoffer Rahm
Journal:  Drugs       Date:  2022-04-12       Impact factor: 11.431

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.